Gentiva Health Services, Inc. (GTIV) has scheduled its third quarter earnings call for October 29th, one week from today. Gentiva reported a second-quarter net income of 59 cents per share which was much higher than the Zacks Consensus Estimate of 45 cents.
The company boasts of a diversified product portfolio. Its product offerings include home health, hospice, respiratory therapies and home medical equipment. Gentiva serves nearly 500,000 patients annually in more than 380 locations across 39 states. Gentiva has successfully grown primarily through acquisitions. During the past few years, the company has completed multiple acquisitions which have expanded its reach further.
Gentiva continues to look for profitable acquisitions. We have an Outperform rating on the stock.Zacks Investment Research
